Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-FR
Language French French
Date Updated 2021-04-01 2020-07-22
Drug Identification Number 00740748 00740748
Brand name RANITIDINE RANITIDINE
Common or Proper name RANITIDINE -150 RANITIDINE -150
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients RANITIDINE RANITIDINE
Strength(s) 150MG 150MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60, 500 60, 500
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Other (Please describe in comments) Other (Please describe in comments)
Anticipated discontinuation date
Actual discontinuation date
Remaining supply date
Discontinuation status Reversed Reversed
Discontinuation decision reversal yes yes
Tier 3 Status No No
Information on remaining supply
Company comments Regulatory issues- Enjeux réglementaires We are looking to re-introduce into the market Regulatory issues- Enjeux réglementaires
Health Canada comments